The Cohort Study for Asthma in China
Recruiting · NCT05937334 · Observational (researchers observe without assigning treatment) · Lead sponsor: Beijing Chao Yang Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Diagnostic Test: lung function test, chest CT, induced sputum, blood routine test, IgE test, FeNO test, six minutes walk test, questionnaires for asthma
What this trial is about
The study is to establish a standardized asthma cohort study, build an information network platform system and a biospecimen bank for asthma cohort, establish clear follow-up standards and norms, observe the asthma outcomes and identify biomarkers to predict asthma outcomes.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age \>18
- Meet the 2023 edition of GINA asthma diagnostic criteria
- Subjects must sign informed consent prior to study participation, participate in the study according to the protocol and follow up for 2 years
Exclusion criteria
- Suffering from other massive lung tissue destructive diseases such as severe bronchiectasis and tuberculosis
- Severe pleural disease and/or sternal and rib lesions
- Serious uncontrolled disease of other system
- Thoracic or abdominal surgery in the past 3 months
- Eye surgery in the past three months
- Retina detachment
- Myocardial infarction within the last 3 months
- Hospitalized for heart disease within the past 3 months
- Ongoing anti-tuberculosis treatment
- Pregnancy or breast feeding
Where it is running
1 location listed.
- Beijing Chao Yang Hospital - Beijing, Beijing Municipality, China